The University of Michigan Rogel Cancer Center has created a solution to modernize, digitize and scale up the analyses of patient response during cancer trials: a tumor response assessment core or “TRAC,” an innovative approach to analyzing the medical scans of...
University of Michigan Rogel Cancer Center
Category
Michigan Universities Receive $9.2M for Prostate Cancer-based Translational Research
The National Cancer Institute (NCI) Specialized Program of Research Excellence (SPOR) has allocated $9.2 million into a grant for the State of Michigan’s two elite cancer programs including the University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer...
University of Michigan Rogel Cancer Center Studies Targeted Pancreatic Cancer Drug AZD1775 Revealing Promise in Clinical Trials
University of Michigan Rogel Cancer Center researchers have conducted clinical trials with an investigational product targeting pancreatic cancer and the initial results look very promising. The study was titled “Dose Escalation Trial of the Wee1 Inhibitor...